Drug‐Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program

Newly identified genetic variants associated with idiosyncratic drug-induced liver injury

(2022) Andrew Stolz   CURRENT OPINION IN GASTROENTEROLOGY

Incidence and risk factors of drug‐induced liver injury

(2022) Xiaoyun Li et al.   LIVER INTERNATIONAL

Liver Injury Associated with Turmeric—A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]

(2022) Dina Halegoua-DeMarzio et al.   AMERICAN JOURNAL OF MEDICINE

Genetics of drug‐induced liver injury: Current knowledge and future prospects

(2022) Ann K. Daly   CTS-Clinical and Translational Science

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

(2022) Hans L. Tillmann et al.   PLoS One

Trends in prevalence of probable fibrotic non‐alcoholic steatohepatitis in the United States, 1999–2016

(2022) Stefano Ciardullo et al.   LIVER INTERNATIONAL

Role of liver sinusoidal endothelial cells in liver diseases

(2021) Jordi Gracia-Sancho et al.   Nature Reviews Gastroenterology & Hepatology

ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

(2021) Naga P. Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Progress With the All of Us Research Program

(2021) Andrea H. Ramirez et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Validity of International Classification of Diseases, 10th Revision, Codes for Cirrhosis

(2020) Nathan S. Ramrakhiani et al.   DIGESTIVE DISEASES

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

(2019) Elizabeth T. Cirulli et al.   GASTROENTEROLOGY

Role of liver sinusoidal endothelial cells in nonalcoholic fatty liver disease

(2019) Adel Hammoutene et al.   JOURNAL OF HEPATOLOGY

Turmeric-Associated Liver Injury

(2019) Mohamed A. Abdallah et al.   AMERICAN JOURNAL OF THERAPEUTICS

Drug-Induced Liver Injury — Types and Phenotypes

(2019) Jay H. Hoofnagle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overexpression of MHCII by hepatocytes in Alcoholic Hepatitis (AH) compared to Non-alcoholic Steatohepatitis (NASH) and normal controls

(2019) Jiajie G. Lu et al.   ALCOHOL

The “All of Us” Research Program

(2019)   NEW ENGLAND JOURNAL OF MEDICINE

Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?

(2018) Gaby Danan et al.   DRUG SAFETY

Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications

(2018) Kalaiyarasi Kaliyaperumal et al.   JOURNAL OF HEPATOLOGY

Drug-induced liver injury: recent advances in diagnosis and risk assessment

(2017) Gerd A Kullak-Ublick et al.   GUT

Death and liver transplantation within 2 years of onset of drug-induced liver injury

(2017) Paul H. Hayashi et al.   HEPATOLOGY

Amoxicillin–Clavulanate-Induced Liver Injury

(2016) Andrew S. deLemos et al.   DIGESTIVE DISEASES AND SCIENCES

Defining a Patient Population With Cirrhosis

(2016) Edward K. Chang et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Clinical and Histologic Features of Azithromycin-Induced Liver Injury

(2015) Melissa A. Martinez et al.   Clinical Gastroenterology and Hepatology

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

(2015) Naga Chalasani et al.   GASTROENTEROLOGY

Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury

(2015) Seung-Hyun Kim et al.   HEPATOLOGY

Drug-Induced Liver Injury: Morbidity, Mortality, and Hy’s Law

(2014) Arie Regev et al.   GASTROENTEROLOGY

Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset

(2014) Robert J. Fontana et al.   GASTROENTEROLOGY

Mechanisms of Drug-induced Liver Injury

(2013) Liyun Yuan et al.   Clinics in Liver Disease

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

(2013) Einar S. Björnsson et al.   GASTROENTEROLOGY

Drug-induced liver injury in obesity

(2013) Bernard Fromenty   JOURNAL OF HEPATOLOGY

HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity

(2013) Camilla Stephens et al.   PLoS One

Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data

(2012) Janet Shin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury

(2011) Eric S. Orman et al.   Clinical Gastroenterology and Hepatology

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles

(2011) M. Isabel Lucena et al.   GASTROENTEROLOGY

Hepatic safety of antibiotics used in primary care

(2011) R. J. Andrade et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Drug-Induced Liver Injury Network (DILIN) Prospective Study

(2009) Robert J. Fontana et al.   DRUG SAFETY

Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex

(2009) M. Isabel Lucena et al.   HEPATOLOGY